John Wilkin
Stock Analyst at Craig-Hallum
(1.24)
# 3,632
Out of 5,182 analysts
6
Total ratings
50%
Success rate
-3.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Maintains: Buy | $12 → $10 | $2.73 | +266.30% | 2 | Mar 11, 2026 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $14.04 | +6.84% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $33.43 | +34.61% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $5.50 | +45.45% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $4.84 | +499.17% | 1 | Feb 12, 2025 |
Exagen
Mar 11, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $2.73
Upside: +266.30%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $14.04
Upside: +6.84%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $33.43
Upside: +34.61%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $5.50
Upside: +45.45%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $4.84
Upside: +499.17%